Very low carbohydrate diets linked to health benefits in children with type 1 diabetes, largest study of its kind finds
Reports and Proceedings
Updates every hour. Last Updated: 22-Oct-2026 06:16 ET (22-Oct-2026 10:16 GMT/UTC)
Very low carbohydrate (VLC) diets may be associated with health benefits in children with type 1 diabetes (T1D) and were not associated with acute diabetes complications, new research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28 – Oct 2) has found.
Incidence of T1D was increased by 11% in the post-vaccination cohort from September 2014 compared with the pre-vaccination cohort
Study contradicts authors hypothesis that protection from infection would reduce incidence of type 1 diabetes
However additional analyses suggest that the increased incidence of T1D may not be caused by the vaccine and further studies are needed
With $2.3 million in funding from the National Science Foundation, Cary Institute of Ecosystem Studies is leading the creation of the first large-scale public collection of lake metabolism data. The open-access database, called the Global LAke Metabolism Repository (GLAMR), will help scientists better understand trends in lake health across the world. Cary is receiving $1 million of the award, with the remaining funds supporting project partners at the University of Colorado Boulder, Grand Valley State University, and the University of Wisconsin-Madison.
The Icahn School of Medicine at Mount Sinai will award its 2026 Yergin Family International Prize for Biomedical Research to Napoleone Ferrara, MD, Distinguished Professor of Pathology and Hildyard Endowed Chair in Eye Disease at the University of California San Diego School of Medicine. The award honors his discovery of vascular endothelial growth factor (VEGF), a molecule that plays a central role in the growth of blood vessels. The prize, which has been renamed this year in recognition of the Yergin family’s longstanding support, was previously known as the Yergin-New International Prize for Biomedical Research. It commemorates Maria I. New, MD, a groundbreaking Mount Sinai pediatric endocrinologist who passed away in 2024.
Historically, medical research has relied heavily on male participants, with findings often generalized to women and children. If women’s health is discussed at all, it’s largely framed around reproduction. In this Special Issue of Science, four Reviews and a Perspective highlight the research that is seeking to close the critical gaps in women’s health. “Overall, it is becoming increasingly clear that women’s health and sex-dependent biological differences go well beyond reproduction and affect people throughout their lifespan and across different medical conditions,” write Science Senior Editor, Yevgenia Nusinovich and colleagues.
It has long been recognized that millions of women, especially younger women, are disproportionately affected by pain disorders; women experience functional pain disorders at roughly twice the rate of men, with some conditions showing an even greater disparity. Persistent pain can be especially debilitating when it affects the pelvis, where disorders involving the gut, bladder, and reproductive organs, including IBS, endometriosis, and vulvodynia, can produce unpredictable symptoms. In this Review, Archana Venkataraman and colleagues synthesize recent advances in understanding these conditions, focusing on the roles of sex hormones, immune-neural interactions, the gut microbiome, and endogenous analgesic pathways; fluctuations in ovarian hormones beginning at puberty appear to be a major contributor, they say. While a growing body of research is beginning to illuminate how hormonal signals interact in women’s bodies to produce sex differences, major gaps remain between the widespread burden of pain among women and the scientific efforts to understand and treat it. “Women are desperately waiting for concrete answers that might help eliminate the common ‘all in your head’ approach to their illnesses, shorten the long wait between symptoms and diagnosis/treatment, and ultimately provide mechanism-based strategies for disease treatment,” write the authors.
Menopause research has historically been underfunded and understudied, despite its enormous impact on half of the human population and nearly 40% of a woman’s lifespan. In a second Review, Larua Gravelsins and colleagues argue that menopause research needs a major rethink, shifting from a one-size-fits-all view of the transition to a precision-medicine approach that accounts for differences in symptoms, timing, genetics and hormone treatments. The authors say this shift could help address the persistent gaps in understanding menopause and menopause hormone therapy. “Diminishing menopause to ’just aging’ is a disservice to women,” write Gravelsins et al. “Menopause is a full-body, hormonally driven change that, like other endogenous hormonal transitions, affects individuals differently based on their individual biology and life experience.”
In a third Review, Dan Corral and Yasmine Belkaid highlight the emerging research surrounding the immune system’s role in preparing a mother’s body for pregnancy. Pregnancy triggers one of the most extensive periods of physiological remodeling in adult life, requiring coordinated changes across nearly every maternal organ. While these changes have traditionally been attributed largely to hormones, new research shows that the immune system actively directs this remodeling, reprogramming maternal tissues in ways that may influence health well beyond pregnancy. Yet despite its profound biological importance, the mechanisms underlying this transformation remain incompletely understood and have historically been understudied.
The final Review by Dena Dubal and colleagues examines how XX and XY chromosomes influence aging and diseases, including neurological, immune, cancer, and cardiometabolic disorders. According to the authors, the collective findings from these studies emphasize the importance of integrating sex chromosome biology into precision medicine and have important implications for future therapeutics and clinical trial design.
In a Perspective, Michael Stout and Francesca Duncan discuss how the ovaries influence health after menopause. The postmenopausal ovary has long been viewed as a largely dormant organ once its reproductive function ends, but growing evidence suggests it remains biologically active for decades after menopause. Determining the ovary’s postmenopausal functions, and whether removing it after menopause affects long-term health, will require further research.
New research shows that X and Y chromosomes drive risk of diseases, including cancer, independent of hormones. Understanding these mechanisms could drive sex-aware medicine.
People who recovered from COVID-19 infection or were vaccinated against SARS-CoV-2 are more likely to have immunity to other closely related bat coronaviruses that could have the potential to threaten future human health.